Related references
Note: Only part of the references are listed.CYP24A1 as a Potential Target for Cancer Therapy
Toshiyuki Sakaki et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention Trial
Alan R. Kristal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Inhibition of the Transition of Ductal Carcinoma In Situ to Invasive Ductal Carcinoma by a Gemini Vitamin D Analog
Joseph Wahler et al.
CANCER PREVENTION RESEARCH (2014)
Increased Dietary Vitamin D Suppresses MAPK Signaling, Colitis, and Colon Cancer
Stacey Meeker et al.
CANCER RESEARCH (2014)
Phase I Safety and Pharmacodynamic of Inecalcitol, a Novel VDR Agonist with Docetaxel in Metastatic Castration-Resistant Prostate Cancer Patients
Jacques Medioni et al.
CLINICAL CANCER RESEARCH (2014)
Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: Systematic review and meta-analysis of prospective cohort studies
Haifa Maalmi et al.
EUROPEAN JOURNAL OF CANCER (2014)
Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies
Mounia Tannour-Louet et al.
FASEB JOURNAL (2014)
Novel Gemini vitamin D-3 analogs: Large structure/function analysis and ability to induce antimicrobial peptide
Ryoko Okamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Thematic Review Series: Fat-Soluble Vitamins: Vitamin D Cytochrome P450-mediated metabolism of vitamin D
Glenville Jones et al.
JOURNAL OF LIPID RESEARCH (2014)
MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro
Kun-Chun Chiang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
Joshua D. Solomon et al.
MOLECULAR CANCER RESEARCH (2014)
VDR Status Arbitrates the Prometastatic Effects of Tumor-Associated Macrophages
Yan Zhang et al.
MOLECULAR CANCER RESEARCH (2014)
Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer
Adebusola Alagbala Ajibade et al.
PLOS ONE (2014)
The future of vitamin D analogs
Carlien Leyssens et al.
FRONTIERS IN PHYSIOLOGY (2014)
The role of vitamin D in reducing cancer risk and progression
David Feldman et al.
NATURE REVIEWS CANCER (2014)
Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Stefan Pilz et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis
Julia Hoebaus et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model
Magdalena Milczarek et al.
BMC CANCER (2013)
Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis
April A. N. Rose et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Molecular Mechanisms of Vitamin D Action
Mark R. Haussler et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol
Yingyu Ma et al.
CANCER (2013)
Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer A feasibility trial
Julia A. Lawrence et al.
CANCER BIOLOGY & THERAPY (2013)
Vitamin D and breast cancer: Emerging concepts
Rajendra G. Mehta et al.
CANCER LETTERS (2013)
Oral Administration of a Gemini Vitamin D Analog, a Synthetic Triterpenoid and the Combination Prevents Mammary Tumorigenesis Driven by ErbB2 Overexpression
Jae Young So et al.
CANCER PREVENTION RESEARCH (2013)
Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system
Yingyu Ma et al.
CELL CYCLE (2013)
Vitamin D - Pivotal Nutraceutical in the Regulation of Cancer Metastasis and Angiogenesis
Jun Xu et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells
Jianwei Zhang et al.
CYTOTECHNOLOGY (2013)
Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer
Carlien Leyssens et al.
ENDOCRINE-RELATED CANCER (2013)
Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma
Anja Urbschat et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
1α,25-Dihydroxyvitamin D3 Stimulates Activin A Production to Fine-Tune Osteoblast-Induced Mineralization
V. J. Woeckel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Vitamin D Level and Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Risk
Kavitha K. Reddy
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Diastereotopic and Deuterium Effects in Gemini
Hubert Maehr et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Associations between vitamin D deficiency and risk of aggressive breast cancer in African-American women
Song Yao et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Down-Regulation of Vitamin D Receptor in Mammospheres: Implications for Vitamin D Resistance in Breast Cancer and Potential for Combination Therapy
Shehla Pervin et al.
PLOS ONE (2013)
Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer
Jae Young So et al.
PLOS ONE (2013)
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin
Jason Gee et al.
PROSTATE (2013)
Effects of Vitamin D3, Calcipotriol and FTY720 on the Expression of Surface Molecules and Cytolytic Activities of Human Natural Killer Cells and Dendritic Cells
Zaidoon Al-Jaderi et al.
TOXINS (2013)
Vitamin D in plants: a review of occurrence, analysis, and biosynthesis
Rie B. Japelt et al.
FRONTIERS IN PLANT SCIENCE (2013)
Immune Regulatory Activity of Vitamin D3 in Head and Neck Cancer
M. Young et al.
Cancers (2013)
Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells
Magdalena Milczarek et al.
Cancers (2013)
Vitamin D Is a Multilevel Repressor of Wnt/b-Catenin Signaling in Cancer Cells
María Larriba et al.
Cancers (2013)
Vitamin D, Sunlight and Cancer Connection
Michael F. Holick
Anti-Cancer Agents in Medicinal Chemistry (2012)
The in-vitro antiproliferative effect of PRI-2191 and imatinib applied in combined treatment with cisplatin, idarubicin, or docetaxel on human leukemia cells
Marta Switalska et al.
ANTI-CANCER DRUGS (2012)
Cellular and molecular effects of vitamin D on carcinogenesis
JoEllen Welsh
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Vitamin D, multiple sclerosis and inflammatory bowel disease
Margherita T. Cantorna
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Where is the vitamin D receptor?
Yongji Wang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D
Glenville Jones et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Vitamin D and cancer: a review of molecular mechanisms
James C. Fleet et al.
BIOCHEMICAL JOURNAL (2012)
1α,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells
Hanna Bessler et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.
Dana E. Rollison et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade
Rebecca Gilbert et al.
CANCER CAUSES & CONTROL (2012)
Application of vitamin D and derivatives in hematological malignancies
Minji Kim et al.
CANCER LETTERS (2012)
A Positive Feedback Signaling Loop between ATM and the Vitamin D Receptor Is Critical for Cancer Chemoprevention by Vitamin D
Huei-Ju Ting et al.
CANCER RESEARCH (2012)
Vitamin D resistance and colon cancer prevention
Charles Giardina et al.
CARCINOGENESIS (2012)
Synthetically Accessible Non-Secosteroidal Hybrid Molecules Combining Vitamin D Receptor Agonism and Histone Deacetylase Inhibition
Joshua Fischer et al.
CHEMISTRY & BIOLOGY (2012)
Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line
J. Meephansan et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2012)
Potent 19-norvitamin D analogs for prostate and liver cancer therapy
Atsushi Kittaka et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer
Albert S. Baldwin
IMMUNOLOGICAL REVIEWS (2012)
Inecalcitol, an analog of 1a,25(OH)2D3, induces growth arrest of androgen-dependent prostate cancer cells
Ryoko Okamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498
Ravi Kasiappan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Altered Expression of Key Players in Vitamin D Metabolism and Signaling in Malignant and Benign Thyroid Tumors
Isabelle Clinckspoor et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Suppressive Effect of 19-nor-1α-25-Dihydroxyvitamin D2 on Gastric Cancer Cells and Peritoneal Metastasis Model
Mi Ra Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
Vitamin D in cutaneous carcinogenesis
Jean Y. Tang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Does vitamin D protect against DNA damage?
Visalini Nair-Shalliker et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)
Pre-Diagnostic Plasma 25-Hydroxyvitamin D Levels and Risk of Non-Melanoma Skin Cancer in Women
Geyu Liang et al.
PLOS ONE (2012)
Mechanism of action of vitamin D and the vitamin D receptor in colorectal cancer prevention and treatment
Stephen W. Byers et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2012)
Vitamin D and the skin: Physiology and pathophysiology
Daniel D. Bikle
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2012)
Vitamin D in combination cancer treatment
Yingyu Ma et al.
Journal of Cancer (2012)
Vitamin D and Cancer
Laura Vuolo et al.
Frontiers in Endocrinology (2012)
Relative Expression of Vitamin D Hydroxylases, CYP27B1 and CYP24A1, and of Cyclooxygenase-2 and Heterogeneity of Human Colorectal Cancer in Relation to Age, Gender, Tumor Location, and Malignancy: Results from Factor and Cluster Analysis
Wolfgang Brozek et al.
Cancers (2012)
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Rohini Roy et al.
NATURE REVIEWS CANCER (2012)
Suppression of Prostate Cancer Cell Rolling and Adhesion to Endothelium by 1α,25-Dihydroxyvitamin D3
Jong-Wei Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D
Aruna V. Krishnan et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Vitamin D and Nonmelanoma Skin Cancer in a Health Maintenance Organization Cohort
Melody J. Eide et al.
ARCHIVES OF DERMATOLOGY (2011)
The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3
E. Vanoirbeek et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitarnin D3: Genomic and non-genomic mechanisms
Mark R. Haussler et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Regulation of vitamin D metabolism
Helen L. Henry
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Cytochromes P450 are essential players in the vitamin D signaling system
Inge Schuster
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia
Tait D. Shanafelt et al.
BLOOD (2011)
High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives
Z. Janjetovic et al.
BRITISH JOURNAL OF CANCER (2011)
Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells
Sophia L. Maund et al.
CANCER RESEARCH (2011)
Eldecalcitol A Review of its Use in the Treatment of Osteoporosis
Mark Sanford et al.
DRUGS (2011)
1,25(OH)2Vitamin D3 Stimulates Myogenic Differentiation by Inhibiting Cell Proliferation and Modulating the Expression of Promyogenic Growth Factors and Myostatin in C2C12 Skeletal Muscle Cells
Leah A. Garcia et al.
ENDOCRINOLOGY (2011)
Expression of vitamin D receptor decreases during progression of pigmented skin lesions
Anna A. Brozyna et al.
HUMAN PATHOLOGY (2011)
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma
Sara Gandini et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Effects of 25-Hydroxyvitamin D3 on Proliferation and Osteoblast Differentiation of Human Marrow Stromal Cells Require CYP27B1/1α-Hydroxylase
Shuo Geng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Suppression of PTH by the Vitamin D Analog Eldecalcitol Is Modulated by its High Affinity for the Serum Vitamin D-Binding Protein and Resistance to Metabolism
Cynthia S. Ritter et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Vitamin D Receptor Protein Expression in Tumor Tissue and Prostate Cancer Progression
Whitney K. Hendrickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Association Between Vitamin D and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies
Yanlei Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D3 in human prostate cells
Eiji Munetsuna et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer
Malini Srinivasan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells
Diego Iglesias-Gato et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Colonic vitamin D metabolism: Implications for the pathogenesis of inflammatory bowel disease and colorectal cancer
Heide S. Cross et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Vitamin D metabolism and action in the prostate: Implications for health and disease
Srilatha Swami et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
A Novel Gemini Vitamin D Analog Represses the Expression of a Stem Cell Marker CD44 in Breast Cancer
Jae Young So et al.
MOLECULAR PHARMACOLOGY (2011)
Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells
James L. Thorne et al.
NUCLEIC ACIDS RESEARCH (2011)
MNU-induced mammary gland carcinogenesis: Chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways
Dana Macejova et al.
TOXICOLOGY LETTERS (2011)
Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women
Laura N. Anderson et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog
Liron Berkovich et al.
ANTI-CANCER DRUGS (2010)
Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions
Nair Lopes et al.
BMC CANCER (2010)
1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1
Pavlo L. Kovalenko et al.
BMC GENOMICS (2010)
22-Oxa-1,25-Dihydroxyvitamin D3 Efficiently Inhibits Tumor Growth in Inoculated Mice and Primary Histoculutre of Cholangiocarcinoma
Wunchana Seubwai et al.
CANCER (2010)
Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men
Jean Y. Tang et al.
CANCER CAUSES & CONTROL (2010)
Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
Perry Stambolsky et al.
CANCER CELL (2010)
Serum 25(OH) Vitamin D and Risk of Breast Cancer: A Nested Case-Control Study from the French E3N Cohort
Pierre Engel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Effects of Supplemental Vitamin D and Calcium on Oxidative DNA Damage Marker in Normal Colorectal Mucosa: A Randomized Clinical Trial
Veronika Fedirko et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Plasma 25-Hydroxyvitamin D Levels and the Risk of Colorectal Cancer: The Multiethnic Cohort Study
Christy G. Woolcott et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Vitamin D: Considerations in the Continued Development as an Agent for Cancer Prevention and Therapy
Donald L. Trump et al.
CANCER JOURNAL (2010)
ApcMIN modulation of vitamin D secosteroid growth control
Haibo Xu et al.
CARCINOGENESIS (2010)
Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment
Aruna V. Krishnan et al.
ENDOCRINE-RELATED CANCER (2010)
Nuclear Targeting of Cyclin-Dependent Kinase 2 Reveals Essential Roles of Cyclin-Dependent Kinase 2 Localization and Cyclin E in Vitamin D-Mediated Growth Inhibition
Omar Flores et al.
ENDOCRINOLOGY (2010)
Vitamin D Metabolism and Action in Human Bone Marrow Stromal Cells
Shuanhu Zhou et al.
ENDOCRINOLOGY (2010)
CYP24A1 Inhibition Enhances the Antitumor Activity of Calcitriol
Josephia R. Muindi et al.
ENDOCRINOLOGY (2010)
Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrate-induced and 5-aza-2′-deoxycytidine-induced PTEN upregulation
Lina Pan et al.
FEBS JOURNAL (2010)
Reactive oxygen species, cellular redox systems, and apoptosis
Magdalena L. Circu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Primary Prevention of Colorectal Cancer
Andrew T. Chan et al.
GASTROENTEROLOGY (2010)
Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU
Guangming Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn Disease
Tian-Tian Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Constitutive Activation of the Mitogen-Activated Protein Kinase Pathway Impairs Vitamin D Signaling in Human Prostate Epithelial Cells
Zhentao Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal Tumorigenesis
Henrik C. Horvath et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Vitamin D Production After UVB Exposure Depends on Baseline Vitamin D and Total Cholesterol But Not on Skin Pigmentation (vol 130, pg 546, 2010)
Bogh
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Down-regulation of NF-κB signals is involved in loss of 1α,25-dihydroxyvitamin D3 responsiveness
Bo-Ying Bao et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Expression of the vitamin D receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer
Martin Blomberg Jensen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Expression of vitamin D receptor (VDR), cyclooxygenase-2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and malignant ovarian tissue and 25-hydroxycholecalciferol (25(OH2)D3) and prostaglandin E2 (PGE2) serum level in ovarian cancer patients
Marc Thill et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Epidemiology of vitamin D and colorectal cancer: Casual or causal link?
Edward Giovannucci
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Cholecalciferol Supplementation Alters Calcitriol-Responsive Monocyte Proteins and Decreases Inflammatory Cytokines in ESRD
Jason R. Stubbs et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Stimulation of Sirt1-Regulated FoxO Protein Function by the Ligand-Bound Vitamin D Receptor
Beum-Soo An et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Regulation of Muscle Mass by Follistatin and Activins
Se-Jin Lee et al.
MOLECULAR ENDOCRINOLOGY (2010)
1α,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells
Anfernee Kai-Wing Tse et al.
MOLECULAR IMMUNOLOGY (2010)
Multicenter phase II trial of vitamin K2 monotherapy and vitamin K2 plus 1α-hydroxyvitamin D3 combination therapy for low-risk myelodysplastic syndromes
Nobu Akiyama et al.
LEUKEMIA RESEARCH (2010)
Vitamin D-3-driven signals for myeloid cell differentiation-Implications for differentiation therapy
Philip J. Hughes et al.
LEUKEMIA RESEARCH (2010)
Cathepsin L, target in cancer treatment?
Jacqueline M. Lankelma et al.
LIFE SCIENCES (2010)
T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism
Kristina Edfeldt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Autophagy as a basis for the health-promoting effects of vitamin D
Maria Hoyer-Hansen et al.
TRENDS IN MOLECULAR MEDICINE (2010)
The Relationship Between Vitamin D and Breast Cancer Incidence and Natural History
Qamar J. Khan et al.
CURRENT ONCOLOGY REPORTS (2010)
Vitamin D Production after UVB Exposure Depends on Baseline Vitamin D and Total Cholesterol but Not on Skin Pigmentation
Morten K. B. Bogh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Valeria Pala et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Vitamin D intake and breast cancer risk: a case-control study in Italy
M. Rossi et al.
ANNALS OF ONCOLOGY (2009)
Vitamin D Gene Pathway Polymorphisms and Risk of Colorectal, Breast, and Prostate Cancer
Marjorie L. McCullough et al.
Annual Review of Nutrition (2009)
Anti- and pro-tumor functions of autophagy
Eugenia Morselli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study
Jeongseon Kim et al.
BMC CANCER (2009)
Association between serum 25(OH) D and death from prostate cancer
S. Tretli et al.
BRITISH JOURNAL OF CANCER (2009)
Effects of Vitamin D and Calcium on Proliferation and Differentiation In Normal Colon Mucosa: a Randomized Clinical Trial
Veronika Fedirko et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Vitamin D Receptor Expression Is Associated with PIK3CA and KRAS Mutations in Colorectal Cancer
Shoko Kure et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivo
Ivy Chung et al.
CANCER RESEARCH (2009)
Vitamin D and differentiation in cancer
Elzbieta Gocek et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility
Petra Massoner et al.
ENDOCRINE-RELATED CANCER (2009)
Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands
Mihwa Choi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Butyrate and Vitamin D3 Induce Transcriptional Attenuation at the Cyclin D1 Locus in Colonic Carcinoma Cells
Sandra Maier et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
1,25-Dihydroxyvitamin D3 Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype
Lajos Szeles et al.
JOURNAL OF IMMUNOLOGY (2009)
Anti-inflammatory effect of 1 alpha,25-dihydroxyvitamin D-3 in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease
Yasuo Suzuki et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells
Vandanajay Bhatia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Human CYP24 Catalyzing the Inactivation of Calcitriol Is Post-Transcriptionally Regulated by miR-125b
Sayaka Komagata et al.
MOLECULAR PHARMACOLOGY (2009)
Vitamin D: emerging new roles in insulin sensitivity
Dorothy Teegarden et al.
NUTRITION RESEARCH REVIEWS (2009)
Control of TCF-4 Expression by VDR and Vitamin D in the Mouse Mammary Gland and Colorectal Cancer Cell Lines
Marcy E. Beildeck et al.
PLOS ONE (2009)
Gene Profiling and Pathway Analysis of Neuroendocrine Transdifferentiated Prostate Cancer Cells
Ryutaro Mori et al.
PROSTATE (2009)
The Vitamin D Receptor Agonist Elocalcitol Inhibits IL-8-Dependent Benign Prostatic Hyperplasia Stromal Cell Proliferation and Inflammatory Response by Targeting the RhoA/Rho Kinase and NF-κB Pathways
Giuseppe Penna et al.
PROSTATE (2009)
Dietary calcium, vitamin D, and the risk of colorectal cancer
Junko Ishihara et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells
Mukul K. Mittal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer - Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel
Tomasz M. Beer et al.
CANCER (2008)
19-nor-1 alpha,25-dihydroxyvitamin D-2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo
Gary G. Schwartz et al.
CANCER BIOLOGY & THERAPY (2008)
Diet, autophagy, and cancer: A review
Keith Singletary et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Roger Bouillon et al.
ENDOCRINE REVIEWS (2008)
Protective role of 1α, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells
Bo-Ying Bao et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prospective study of combined treatment with interferon-alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma
Wataru Obara et al.
INTERNATIONAL JOURNAL OF UROLOGY (2008)
Vitamin D3 induces autophagy of human myeloid leukemia cells
Jianrong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Selective inhibition of cyclooxygenase-2 (COX-2) by 1α,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog
Rachamallu Aparna et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Mammary Epithelial Cell Transformation Is Associated With Deregulation of the Vitamin D Pathway
Carly M. Kemmis et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Vitamin D analogs: Therapeutic applications and mechanisms for selectivity
Alex J. Brown et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Vitamin D3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57
Lianjun Lu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Vitamin D's role in cell proliferation and differentiation
Sam Samuel et al.
NUTRITION REVIEWS (2008)
DICKKOPF-4 is induced by TCF/β-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1α, 25-dihydroxyvitamin D3
N. Pendas-Franco et al.
ONCOGENE (2008)
The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells
Lihong Peng et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population
Esther M. John et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
The TGFβ/Smad 3-signaling pathway is involved in butyrate-mediated vitamin D receptor (VDR)-expression
Carolin Daniel et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
1α-Hydroxyvitamin D2 inhibits growth of human neuroblastoma
Paul R. van Ginkel et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
CYP27A1 and CYP24 expression as a function of malignant transformation in the colon
Damien Matusiak et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Prospective study of serum vitamin D and cancer mortality in the United States
D. Michal Freedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Chemopreventive effect of a vitamin D3 analog, alfacalcidol, on colorectal carcinogenesis in mice with ulcerative colitis
Hiroyuki Kikuchi et al.
ANTI-CANCER DRUGS (2007)
Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo
Meggan E. Valrance et al.
ENDOCRINOLOGY (2007)
Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: The effect of UVB dose and skin color
Laura A. G. Armas et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1α,25-dihydroxyvitamin D3 responsiveness
Huei-Ju Ting et al.
MOLECULAR CANCER RESEARCH (2007)
Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NFKB signalling
Markus Schwab et al.
MOLECULAR IMMUNOLOGY (2007)
Vitamin D receptor is essential for normal keratinocyte stem cell function
Luisella Cianferotti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
High-throughput system for analyzing ligand-induced cofactor recruitment by vitamin D receptor
Midori A. Arai et al.
BIOCONJUGATE CHEMISTRY (2007)
1α,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells
Moshe Ben-Shoshan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1α,25-dihydroxyvitamin D3
Huei-Ju Ting et al.
CANCER LETTERS (2007)
Vitamin D and prevention of breast cancer: Pooled analysis
Cedric F. Garland et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Selective vitamin D receptor modulators and their effects on colorectal tumor growth
C. S. Spina et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer
Aruna V. Krishnan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
1α,25-dihydroxyvitamin D and fish oil synergistically inhibit G1/S-phase transition in prostate cancer cells
N. W. Istfan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines
Josephia R. Muindi et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol)
Luciano Adorini et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells
Belinda Byrne et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Vitamin D regulates the phenotype of human breast cancer cells
Natalia Pendas-Franco et al.
DIFFERENTIATION (2007)
Vitamin D and reduced risk of breast cancer: A population-based case-control study
Julia A. Knight et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-β, and Bcl-2
Maria Hoyer-Hansen et al.
MOLECULAR CELL (2007)
Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery
Gerald DeMasters et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Evidence that both 1α,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization
M. van Driel et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
1α, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis
Bo-Ying Bao et al.
CARCINOGENESIS (2006)
Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth
James R. Lambert et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck
Claudia Gedlicka et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2006)
Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer
Hong Jin Lee et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Fish consumption and breast cancer risk.: The European Prospective Investigation into Cancer and Nutrition (EPIC)
D Engeset et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells
S Marchiani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
2MD, a new anabolic agent for osteoporosis treatment
LA Plum et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation
Reo Maruyama et al.
CANCER RESEARCH (2006)
The molecular basis of vitamin D receptor and β-catenin crossregulation
S Shah et al.
MOLECULAR CELL (2006)
Free radicals, metals and antioxidants in oxidative stress-induced cancer
M Valko et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Calcium plus vitamin D supplementation and the risk of colorectal cancer
J Wactawski-Wende et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Convergence of vitamin D and retinoic acid signalling at a common hormone response element
L Tavera-Mendoza et al.
EMBO REPORTS (2006)
Expression of VDR and CYP24A1 mRNA in human tumors
MG Anderson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells
Ivy Chung et al.
CANCER RESEARCH (2006)
Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis
Geraldine Flynn et al.
ONCOLOGY (2006)
Phase I/II study of 19-nor-1α-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer
GG Schwartz et al.
CLINICAL CANCER RESEARCH (2005)
Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses
CS Moreno et al.
CANCER RESEARCH (2005)
E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer:: clinicopathological correlations
C Peña et al.
HUMAN MOLECULAR GENETICS (2005)
Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis
XH Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression of vitamin D receptor and 25-hydroxyvitamin D3-1α-hydroxylase in normal and malignant human colon
D Matusiak et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines
S Kawa et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia
HZ Ke et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death
M Hoyer-Hansen et al.
CELL DEATH AND DIFFERENTIATION (2005)
The Vitamin D endocrine system of the gut -: Its possible role in colorectal cancer prevention
HS Cross et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer
ER Bertone-Johnson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Noncalcemic actions of vitamin D receptor ligands
S Nagpal et al.
ENDOCRINE REVIEWS (2005)
Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3
AF Gombart et al.
FASEB JOURNAL (2005)
22-oxa-1α,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer
K Nakagawa et al.
CARCINOGENESIS (2005)
Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population
LC Lowe et al.
EUROPEAN JOURNAL OF CANCER (2005)
19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia
T Kumagai et al.
CANCER RESEARCH (2005)
Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines
FZ Li et al.
ONCOGENE (2005)
Regulation of multiple insulin-like growth factor binding protein genes by 1 alpha,25-dihydroxyvitamin D-3
M Matilainen et al.
NUCLEIC ACIDS RESEARCH (2005)
Anti-endothelial properties of 1,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of calcitriol
P Furigay et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Analysis of the vitamin D system in cutaneous squamous cell carcinomas
J Reichrath et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2004)
Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer
K Mimori et al.
ANNALS OF ONCOLOGY (2004)
Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191)
J Wietrzyk et al.
STEROIDS (2004)
Cutting edge:: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression
TT Wang et al.
JOURNAL OF IMMUNOLOGY (2004)
The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer
HG Pálmer et al.
NATURE MEDICINE (2004)
Co-operative functions between nuclear factors NFκB and CCAT/enhancer-binding protein-β (C/EBP-β) regulate the IL-6 promoter in autocrine human prostate cancer cells
WH Xiao et al.
PROSTATE (2004)
Analysis of the vitamin D system in basal cell carcinomas (BCCs)
T Mitschele et al.
LABORATORY INVESTIGATION (2004)
Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays
AV Krishnan et al.
PROSTATE (2004)
1α,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway
S Murthy et al.
PROSTATE (2004)
Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis
DM Peehl et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter
LH Peng et al.
MOLECULAR ENDOCRINOLOGY (2004)
19-Nor-1α,25-dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations
I Molnár et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer
F Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm
ES Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vitamin D and prostate cancer prevention and treatment
TC Chen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
Efficient synthesis of 2-modified 1α,25-dihydroxy-19-norvitamin D3 with Julia Olefination:: High potency in induction of differentiation on HL-60 cells
K Ono et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
Photodynamic therapy with photofrin in combination with Buthionine Sulfoximine (BSO) of human glioma in the nude rat
F Jiang et al.
LASERS IN MEDICAL SCIENCE (2003)
Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein
S Ryhänen et al.
BIOCHEMICAL PHARMACOLOGY (2003)
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
K Dalhoff et al.
BRITISH JOURNAL OF CANCER (2003)
Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray
S Swami et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2:: Antitumor activity against leukemia, myeloma, and colon cancer cells
T Kumagai et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Melatonin and vitamin D3 increase TGF-β1 release and induce growth inhibition in breast cancer cell cultures
M Bizzarri et al.
JOURNAL OF SURGICAL RESEARCH (2003)
Anti-proliferative effects of 20-epi-vitamin-D3 analogue, KH1060 in human neuroblastoma:: induction of RAR-β and p21Cip1
K Gumireddy et al.
CANCER LETTERS (2003)
Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion
L Flanagan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue
C Crescioli et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer
GM Oades et al.
BJU INTERNATIONAL (2002)
Transforming growth factor-β1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3
AP Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Combination of 22-oxa-1,25-dihydroxyvitamin D3, a vitamin D3 derivative, with vitamin K2 (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells
K Funato et al.
LEUKEMIA (2002)
A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand
DJ Bettoun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Antiproliferative effects of 1α,25-dihydroxyvitamin D3 and vitamin D analogs on tumor-derived endothelial cells
RJ Bernardi et al.
ENDOCRINOLOGY (2002)
Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation
R Lin et al.
MOLECULAR ENDOCRINOLOGY (2002)
Vitamin D and vitamin D analogs in cancer treatment
GJCM van den Bemd et al.
CURRENT DRUG TARGETS (2002)
ZK 156718, a low calcemic, antiproliferative, and prodifferentiating vitamin D analog
T Gaschott et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
'Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents
F Tosetti et al.
FASEB JOURNAL (2002)
Synthetic low-calcaemic vitamin D3 analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells
YS Oh et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Autocrine TGFβ signaling mediates vitamin D3 analog-induced growth inhibition in breast cells
LM Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Regulation of proliferation of prostate epithelial cells by 1,25-dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3
CC Sprenger et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Inhibitory effects of 1α,25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery
SS Jensen et al.
MOLECULAR ENDOCRINOLOGY (2001)
Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling
HG Pálmer et al.
JOURNAL OF CELL BIOLOGY (2001)
The vitamin D3 analog, ILX-23-7553, enhances the response to Adriamycin and irradiation in MCF-7 breast tumor cells
M Chaudhry et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Insulin-like growth factor binding protein-3 mediates 1α,25-dihydroxyvitamin D3 growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1
BJ Boyle et al.
JOURNAL OF UROLOGY (2001)
History of the development of new vitamin D analogs:: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71)
Y Nishii et al.
STEROIDS (2001)
Vitamin D3 analogs (MC 1288, KH 1060, EB 1089, CS 1558, and CB 1093):: studies on their mechanism of action
PH Mäenpää et al.
STEROIDS (2001)
Interactions of vitamin D analogue CB1093, TNFα and ceramide on breast cancer cell apoptosis
G Pirianov et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol
P Trouillas et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Expression patterns of vitamin D receptor in human prostate
D Krill et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
The anti-proliferative effects of 1α,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression
MJ Campbell et al.
ONCOGENE (2000)
1α,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo
DJ Mantell et al.
CIRCULATION RESEARCH (2000)
The vitamin D-3 analog EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells
S Sundaram et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Share Paper
